Cost-Utility Analysis of Pharmaceutical Care Intervention Versus Usual Care in Management of Nigerian Patients with Type 2 Diabetes

International Diabetes Federation 2017

Ann M. Carracher, Payal H. Marathe, Kelly L. Close · Journal of Diabetes · 2018 · 13.5K citations · Full text

Global estimates of the prevalence of diabetes for 2010 and 2030

Jonathan E. Shaw, Richard Sicree, Paul Zimmet · Diabetes Research and Clinical Practice · 2009 · 7.2K citations

Obesity, Diabetes Epidemiology, Global Health +8

Methods for the economic evaluation of health care programmes

Sandra Wilson · Journal of Epidemiology & Community Health · 1987 · 4.3K citations · Full text

Health Economics, Health Policy, Outcomes Research +5

Opportunities and responsibilities in pharmaceutical care

Charles D. Hepler, Linda M. Strand · American Journal of Health-System Pharmacy · 1990 · 2.9K citations

Drug Dispensing, Adverse Drug Reaction, Primary Care +16

Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force

Don Husereau, Michael Drummond, Stavros Petrou et al. · Value in Health · 2013 · 2K citations · Full text

Health Systems, Health Policy, Health Impact Assessment +5